ADVFN - Advanced Financial Network.
HOME» NYSE » A » ABT Stock Price » ABT Stock News

Abbott Labs Share News

 Abbott Laboratories Stock Price
ABT Stock Price
 Abbott Laboratories Stock Chart
ABT Stock Chart
 Abbott Laboratories Stock News
ABT Stock News
 Abbott Laboratories Company Information
ABT Company Information
 Abbott Laboratories Stock Trades
ABT Stock Trades

Abbott Laboratories Executive: Planning to Grow Nutrition Business in India

By Rumman Ahmed BANGALORE--Abbott Laboratories (ABT) is looking at having a fully integrated business model to grow its nutrition business in India, where it has plans to add local manufacturing as well as sales and distribution functions to its research and development capabilities, a senior executive said Monday. Abbott Monday inaugurated its first nutrition research and development center in the South Asian nation through a tie-up with a unit of Indian biotechnology company Biocon Ltd. (532523.BY). "India is a growth area for us. We have research now. To be fully integrated, we will have everything from research to manufacturing to sales (in India)," John Landgraf, executive vice president of Abbott's global nutrition business, said in an interview. Mr. Landgraf didn't elaborate on Abbott's plans for setting up local manufacturing operations, but said it is the "next phase" of the company's programs for the nutrition business in India. Abbott had last month unveiled its collaboration with Syngene International Ltd., Biocon's contract research unit, to develop nutrition products targeting those afflicted by malnutrition and diabetes in the South Asian nation. Write to Rumman Ahmed in Bangalore at rumman.ahmed@dowjones.com

Stock News for Abbott Labs (ABT)
DateTimeHeadline
05/02/201613:59:00ST. JUDE MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL...
04/29/201617:37:57Statement of Changes in Beneficial Ownership (4)
04/29/201603:03:00Abbott to Acquire St. Jude -- WSJ
04/29/201602:00:00Alere Says It Rejected Abbott Offer to Terminate Merger Deal
04/29/201601:53:00Alere Says It Rejected Abbott Offer to End Their Merger Deal
04/28/201617:42:00Abbott Agreed to Buy St. Jude in $25 Billion Deal--6th Update
04/28/201610:19:00Abbott Agreed to Buy St. Jude in $25 Billion Deal--5th Update
04/28/201608:35:00Abbott Agreed to Buy St. Jude in $25 Billion Deal--4th Update
04/28/201608:30:00St. Jude Medical (STJ) ALERT: Johnson & Weaver, LLP Launches...
04/28/201608:25:00Abbott Agreed to Buy St. Jude in $25 Billion Deal--3rd Update
04/28/201608:10:00Abbott Agreed to Buy St. Jude in $25 Billion Deal--2nd Update
04/28/201608:04:00Abbott Laboratories Acquisition
04/28/201607:57:00Abbott Agreed to Buy St. Jude in $25 Billion Deal--Update
04/28/201607:50:00Abbott Agreed to Buy St. Jude in $25 Billion Deal
04/28/201607:35:00Abbott Agreed to Buy St. Jude in $25 Billion Deal
04/28/201607:08:16Current Report Filing (8-k)
04/28/201606:50:00Abbott to Acquire St. Jude Medical
04/26/201609:30:00What's the Secret to Living a Full Life? A New Global Survey...
04/21/201609:00:00Abbott Introduces New Services and Tools to Help Labs Deliver...
04/20/201612:21:00Abbott Laboratories Revenue Hurt by Currency Exchange -- Update

Abbott Laboratories and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad